Considerations for Pre-filled Syringes for 503(b) Compounding Facilities

Considerations for Pre-filled Syringes for 503(b) Compounding Facilities

AST, a leading aseptic fill- and finishing machine manufacturer, and SCHOTT, a global expert in drug containment solutions, share their expertise on how to help 503(b) compounding facilities bring acute care drugs to market quicker, provide a safer drug administration process, and minimize healthcare and hospital costs.

AST at CPhI North America

AST at CPhI North America

AST’s Keith Dodson and Chaise DeVries will be at the CPhI North America live event next week, August 10-12. To schedule a meeting, reach out on LinkedIn or contact us. We hope to see you there!